Effective Data Analysis for Nontraditional Study Designs
Firma's Dr. D.J. Tang shares in a Clinical Researcher article insights on effective data analysis for nontraditional study designs.
Global Clinical Trials and In-Home Visits: Preventing Common Pitfalls
More and more global clinical trials are using a hybrid approach to study visits. Find out the biggest challenges--and how to solve them.
6 Common Questions Clinical Research Teams Have About Home Trial Services
What sites and study teams really want to know about using remote, in-home visits as part of their clinical trial protocols. The answers to the most common questions.
Multi-national studies call for informed approach: Firma Clinical Research
Firma’s Dr. D.J. Tang shares in an Outsourcing-Pharma article why RWD can be useful in drug research and development.
Firma Promotes Jennifer Mintz to Chief Commercial Officer
Firma Clinical recently commenced a Scientific Advisory Board for its clinical services, including biometrics/data.
Achieving Clinically Meaningful Treatment Efficacy Summaries: A COVID-19 Case Study
In a recent study, researchers looked at two randomized comparative trials evaluating COVID-19 treatments and outlined the problematic gaps created by the use of the Kaplan-Meier method and hazard ratio.
Real-World Data Use in Clinical Trials Can Yield Real Benefits
Firma’s Dr. D.J. Tang shares in an Outsourcing-Pharma article why RWD can be useful in drug research and development.
FIRMA COMMENCES SCIENTIFIC ADVISORY BOARD
Firma Clinical recently commenced a Scientific Advisory Board for its clinical services, including biometrics/data.
In-Home Services Boost Patient Centricity
In Outsourcing-Pharma, Melissa Nezos, explains how the pandemic increased the need to bring the study to the patient.
Patient-Centric Tools for Today and Tomorrow’s Clinical Trials
Firma’s Melissa Nezos shares in an Applied Clinical Trials article the important role of home visits in hybrid and decentralized/virtual clinical trials.
